KPP Advisory Services’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.46M Buy
9,796
+137
+1% +$29.5K 0.31% 77
2026
Q1
$2.1M Buy
9,659
+68
+0.7% +$15.1K 0.31% 79
2025
Q4
$2.19M Buy
9,591
+771
+9% +$176K 0.32% 74
2025
Q3
$2.04M Sell
8,820
-10
-0.1% -$2.04K 0.3% 76
2025
Q2
$1.64M Buy
8,830
+151
+2% +$28.1K 0.27% 85
2025
Q1
$1.82M Buy
8,679
+2,895
+50% +$563K 0.34% 69
2024
Q4
$1.03M Sell
5,784
-366
-6% -$67.3K 0.24% 90
2024
Q3
$1.21M Sell
6,150
-17
-0.3% -$3.17K 0.29% 74
2024
Q2
$1.06M Buy
6,167
+309
+5% +$51.2K 0.28% 80
2024
Q1
$1.07M Buy
5,858
+541
+10% +$93.2K 0.29% 74
2023
Q4
$824K Sell
5,317
-228
-4% -$33.2K 0.72% 34
2023
Q3
$826K Buy
+5,545
New +$814K 0.27% 73

Other funds holding ABBV

KPP Advisory Services's ABBV Position: Q2 2026 in Review

KPP Advisory Services increased its AbbVie (ABBV) stake by 1.4% in Q2 2026, buying an estimated $29.5K and bringing the position to 9,796 shares worth $2.46M. The position accounts for 0.31% of the portfolio, ranked #77.

KPP Advisory Services first reported a position in ABBV in Q3 2023 and has held it in 12 quarters since. 4,201 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • KPP Advisory Services held 9,796 shares of AbbVie worth $2.46M as of Q2 2026.
  • KPP Advisory Services bought 137 AbbVie shares in Q2 2026, an estimated $29.5K.
  • AbbVie made up 0.31% of KPP Advisory Services's portfolio in Q2 2026, its #77 holding.
  • KPP Advisory Services first reported a position in AbbVie in Q3 2023 and has held it in 12 quarters since.
  • 4,201 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on KPP Advisory Services's 13F filing for Q2 2026, filed 24 Jul 2026.